Industry says failure to consider new ways of assessing the value of drugs, including outcomes-based approaches and the use of real world evidence, represents a missed opportunity to promote sustainability of Europe’s healthcare systems
More prevention, improved primary care and an integrated, patient-centred approach is the route to making health systems resilient. Underpinning all this will be better data, says report on State of Health in the EU
The Paediatric Regulation has “basically forced” companies to tailor drugs for use by children, but more work is needed to plug gaps in the area of childhood rare diseases
Greater certainty about what types of digital health technology will be regulated by FDA will foster innovation and help the agency to devote more resources to higher risk priorities, says Scott Gottlieb
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.